Host factors associated with outcome from primary human immunodeficiency virus-1 infection

被引:6
|
作者
Telenti, Amalio [1 ,2 ]
Carrington, Mary [3 ]
机构
[1] Univ Lausanne, Inst Microbiol, CH-1011 Lausanne, Switzerland
[2] Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland
[3] NCI Frederick, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA
基金
瑞士国家科学基金会; 美国国家卫生研究院;
关键词
genome; HLA antigens; KIR receptors; viral load;
D O I
10.1097/COH.0b013e3282f18ac0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review The early events in human immunodeficiency virus-1 infection are increasingly recognized as critical for the overall evolution of the disease. Viral and host factors interact to establish a point of equilibrium defined by the viral set point. This review highlights new opportunities in the understanding of the genetic and genomic determinants of those early events. Recent findings The field of human immunodeficiency virus host genetics is shifting from the measure of long-term consequences of infection to the analysis of quantitative biological endpoints of viral control, with particular attention on the earliest events as study phenotypes. The field has also been enriched by a better understanding of the determinant and complex role of human leukocyte antigen and killer cell immunoglobulin-like-receptor variation, and by the completion of the first genome-wide study of determinants of human immunodeficiency virus-1 replication. The genome analysis highlights the central influence of acquired immunity in viral control, and provides an extensive catalogue of novel gene candidates. Summary Host genetics and genomic analyses of precise quantitative study phenotypes offer an unprecedented opportunity to dissect critical steps in human immunodeficiency virus-1 pathogenesis.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 50 条
  • [41] Head and neck cancer in patients with human immunodeficiency virus-1 infection: incidence, outcome and association with Epstein-Barr virus
    Powles, T
    Powles, J
    Nelson, M
    Sandison, A
    Peston, D
    Buchannan, J
    Mandalia, S
    Gazzard, B
    Bower, M
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2004, 118 (03): : 207 - 212
  • [42] NATURAL-HISTORY OF VERTICALLY ACQUIRED HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION
    LIDINJANSSON, G
    LJUNG, R
    CHRISTENSSON, B
    MELICA, F
    CIRILLO, C
    BARIGIONE, G
    BELLOMO, M
    CAOCCI, F
    SPRECHER, S
    CLUMECK, N
    GIMENEZ, E
    SIERRA, C
    VINOLAS, M
    LOPEZ, MA
    PEDIATRICS, 1994, 94 (06) : 815 - 819
  • [43] Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?
    Vanham, Guido
    Van Gulck, Ellen
    RETROVIROLOGY, 2012, 9
  • [44] Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo
    Jenkins, M
    Hanley, MB
    Moreno, MB
    Wieder, E
    McCune, JM
    BLOOD, 1998, 91 (08) : 2672 - 2678
  • [45] Adverse cutaneous drug reactions in patients with human immunodeficiency virus-1 infection
    Heller, HM
    CLINICS IN DERMATOLOGY, 2000, 18 (04) : 485 - 489
  • [46] Human Immunodeficiency Virus-1 and Preconception Care
    Margaret A. Lampe
    Maternal and Child Health Journal, 2006, 10 : 195 - 197
  • [47] Can immunotherapy be useful as a “functional cure” for infection with Human Immunodeficiency Virus-1?
    Guido Vanham
    Ellen Van Gulck
    Retrovirology, 9
  • [48] VITAMIN-B12 IN EARLY HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION
    MANTEROATIENZA, E
    BAUM, MK
    MORGAN, R
    WILKIE, F
    SHORPOSNER, G
    FLETCHER, MA
    EISDORFER, C
    BEACH, RS
    ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (05) : 1019 - 1020
  • [49] IMMUNOHISTOCHEMICAL EVIDENCE FOR HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION OF LIVER KUPFFER CELLS
    HOUSSET, C
    BOUCHER, O
    GIRARD, PM
    LEIBOWITCH, J
    SAIMOT, AG
    BRECHOT, C
    MARCHE, C
    HUMAN PATHOLOGY, 1990, 21 (04) : 404 - 408
  • [50] Mechanisms of human immunodeficiency virus-1 latency
    O'Doherty, U
    TRANSFUSION, 2005, 45 (02) : 88S - 91S